ALOX5 and atherosclerosis: Moreover, Fredman et al. [7] also showed decreased levels of 5-LOX SPMs in unstable atherosclerotic lesion in both human samples and murine models of atherosclerosis and one might speculate if the late (1 week after MI) rise in 5-LOX SPMs could inhibit further plaque destabilization.